Psychemedics Corporation (PMD) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 14	$0.08	$0.13	+62.5%	—	$6.8M	—
Q3 14	$0.12	$0.17	+41.7%	—	$7.7M	—
Q2 14	$0.03	$0.16	+433.3%	—	$7.7M	—
Q1 14	$0.12	$0.15	+25.0%	—	$7M	—
Q4 13	$0.12	$0.16	+33.3%	—	$6.5M	—
Q3 13	$0.2	$0.2	0.0%	—	$7.1M	—
Q2 13	$0.19	$0.2	+5.3%	—	$6.9M	—
Q4 11	$0.19	$0.08	-57.9%	—	$5.5M	—
Q3 11	$0.19	$0.21	+10.5%	—	$6.3M	—
Q2 11	$0.16	$0.21	+31.2%	—	$6.2M	—
Q1 11	$0.1	$0.16	+60.0%	—	$6M	—
Q4 10	$0.15	$0.08	-46.7%	—	$5.1M	—
Q3 10	$0.12	$0.16	+33.3%	—	$5.1M	—
Q2 10	$0.1	$0.17	+70.0%	—	$5.4M	—
Q1 10	$0.11	$0.1	-9.1%	—	$4.5M	—
Q4 09	$0.07	$0.1	+42.9%	—	$4.3M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY24	—	—	—	—	$19.7M	—
FY23	—	-$0.72	—	—	$22.1M	—
FY22	—	-$0.19	—	—	$25.2M	—
FY21	—	-$0.12	—	—	$24.9M	—
FY20

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Revenue	$27M	$39M	$39.7M	$42.7M	$37.7M	$21.4M	$24.9M	$25.2M	$22.1M	$19.7M
YoY change	-7.64%	+44.5%	+1.85%	+7.49%	-11.7%	-43.3%	+16.6%	+1.33%	-12.4%	-10.9%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Revenue	27M	39M	39.7M	42.7M	37.7M	21.4M	24.9M	25.2M	22.1M	19.7M
Cost of revenue	14.3M	17.5M	19.9M	22.1M	21.2M	16.5M	14.6M	15.9M	13.7M	12.6M
Gross profit	12.7M	21.4M	19.8M	20.6M	16.4M	4.9M	10.3M	9.3M	8.4M	7.1M
Gross margin	47.1%	55%	49.9%	48.3%	43.6%	22.9%	41.2%	36.8%	38.1%	36.1%
Research & development	1.6M	1.4M	1.4M	1.6M	1.6M	1.3M	1.1M	1.3M	1.1M	749K
Selling, general & administrative	9.6M	9.9M	10.3M	11.5M	11.9M	9.7M	8.9M	9M	10.2M	8.2M
Operating expenses	11.2M	11.3M	11.7M	13M	13.4M	11M	10.1M	10.4M	11.3M	9M
Operating income	1.5M	10.1M	8.2M	7.6M	3M	-6.1M	209K	-1.1M	-2.9M	-1.9M
Operating margin	5.45%	25.9%	20.5%	17.8%	7.96%	-28.4%	0.84%	-4.29%	-13.2%	-9.62%
Non-operating income, net	-124K	-134K	20K	43K	58K	-140K	-1M	43K	-517K	3K
Pretax income	1.3M	10M	8.2M	7.7M	3.1M	-6.2M	-821K	-1M	-3.4M	-1.9M
Income tax	-164K	3.3M	2.1M	3.1M	1.5M	-2.3M	-156K	44K	716K	-55K
Net income	1.5M	6.7M	6.1M	4.6M	1.5M	-3.9M	-665K	-1.1M	-4.2M	-1.9M
Net margin	5.6%	17.1%	15.4%	10.7%	4.09%	-18.1%	-2.67%	-4.29%	-18.8%	-9.45%
EBITDA	3.2M	12.4M	11M	10.7M	5.9M	-2.4M	4.9M	2.2M	256K	193K
EPS	0.28	1.22	1.11	0.83	0.28	-0.7	-0.12	-0.19	-0.72	—
Diluted EPS	0.28	1.22	1.1	0.83	0.28	-0.7	-0.12	-0.19	-0.72	—

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24
Revenue	6.5M	6.5M	6.5M	5.7M	5.9M	5.5M	5.7M	5M	5.4M	4.7M	5.2M	4.4M
Cost of revenue	4.1M	4.2M	4.2M	3.5M	3.7M	3.5M	3.6M	2.9M	3.2M	3.2M	3.1M	3M
Gross profit	2.4M	2.3M	2.3M	2.2M	2.2M	2.1M	2.1M	2.1M	2.1M	1.6M	2M	1.4M
Gross margin	37.5%	34.9%	35.8%	39.4%	37.6%	37.2%	36.7%	41.2%	39.6%	32.8%	39.4%	31.4%
Research & development	318K	357K	328K	323K	298K	286K	275K	285K	209K	189K	172K	179K
Selling, general & administrative	2.1M	2.3M	2.4M	2.3M	2.4M	2.2M	2.9M	2.6M	2.5M	2.3M	2.5M	1M
Operating expenses	2.5M	2.6M	2.7M	2.6M	2.7M	2.5M	3.2M	2.9M	2.7M	2.5M	2.6M	1.2M
Operating income	-10K	-342K	-375K	-356K	-528K	-417K	-1.1M	-868K	-567K	-899K	-595K	168K
Operating margin	-0.15%	-5.25%	-5.76%	-6.24%	-9.01%	-7.53%	-19.4%	-17.4%	-10.6%	-19%	-11.5%	3.8%
Non-operating income, net	66K	-9K	-8K	-6K	-5K	-505K	—	-8K	-5K	1K	-11K	18K
Pretax income	56K	-351K	-383K	-362K	-533K	-922K	-1.1M	-876K	-572K	-898K	-606K	160K
Income tax	17K	-13K	-286K	326K	-149K	-196K	992K	69K	116K	-71K	-71K	-29K
Net income	39K	-338K	-97K	-688K	-384K	-726K	-2.1M	-945K	-688K	-827K	-535K	189K
Net margin	0.6%	-5.19%	-1.49%	-12.1%	-6.55%	-13.1%	-36.8%	-18.9%	-12.8%	-17.5%	-10.3%	4.27%
EBITDA	850K	525K	452K	406K	186K	779K	-422K	-286K	-14K	-235K	-142K	584K
EPS	0.01	-0.06	-0.02	-0.12	-0.07	-0.13	-0.36	—	-0.12	-0.14	-0.09	—
Diluted EPS	0.01	-0.06	-0.02	-0.12	-0.07	-0.13	-0.36	—	-0.12	-0.14	-0.09	—

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	Current
Market cap	54.8M	134.8M	112.9M	87.4M	50.5M	28.2M	39.2M	27.9M	17M	—	13.5M
Enterprise value	58M	134.2M	108.1M	81.1M	49.2M	34.3M	42.4M	26.7M	17.3M	—	13.2M
Shares outstanding	5.4M	5.5M	5.5M	5.5M	5.5M	5.5M	5.6M	5.7M	5.7M	—	—

Valuation

Metric	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	Current
P/E	36.3	20.2	18.4	19.1	32.7	—	—	—	—	—	—
P/S	2.03	3.46	2.84	2.05	1.34	1.32	1.58	1.1	0.77	—	0.69
P/B	4.69	8.63	6.06	4.66	3	2.25	3.2	2.59	2.55	—	—
EV/EBITDA	18.1	10.8	9.86	7.59	8.32	-14	8.7	12	67.7	—	68.6
EV/Sales	2.15	3.44	2.72	1.9	1.3	1.6	1.7	1.06	0.78	—	0.67
Earnings yield	2.76%	4.96%	5.42%	5.25%	3.05%	—	—	—	—	—	—
FCF yield	5.08%	5.32%	7%	7.71%	5.21%	-18%	0.59%	16.9%	-9.63%	—	-13.8%

Profitability

Metric	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	Current
Gross margin	47.1%	55%	49.9%	48.3%	43.6%	22.9%	41.2%	36.8%	38.1%	36.1%	31.4%
Operating margin	5.45%	25.9%	20.5%	17.8%	7.96%	-28.4%	0.84%	-4.29%	-13.2%	-9.62%	-9.6%
Net margin	5.6%	17.1%	15.4%	10.7%	4.09%	-18.1%	-2.67%	-4.29%	-18.8%	-9.45%	36.1%
ROE	12.9%	42.8%	32.9%	24.5%	9.17%	-30.8%	-5.43%	-10.1%	-62.3%	-36.3%	-36.3%
ROA	6.86%	26.7%	23.1%	18.4%	5.6%	-16.1%	-3.09%	-5.79%	-33.7%	-22.4%	-22.4%
ROIC	9.89%	45%	44.1%	36.8%	9.76%	-32.6%	1.36%	-11.3%	-41.7%	-38.8%	-38.8%
Return on tangible assets	6.86%	26.7%	23.1%	18.4%	5.6%	-16.1%	-3.09%	-5.79%	-33.7%	-22.4%	-22.4%

Financial health

Metric	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	Current
Current ratio	2.28	2.41	3.28	3.42	2.2	2.44	1.76	1.74	1.45	1.82	1.82
Quick ratio	2.28	2.41	3.28	3.42	2.2	2.44	1.76	1.74	1.45	1.82	1.82
Debt / equity	0.5	0.22	0.18	0.09	0.35	0.71	0.42	0.33	0.34	0.23	0
Debt / assets	0.27	0.14	0.13	0.07	0.22	0.37	0.24	0.19	0.19	0.14	0.14
Net debt / EBITDA	1	-0.04	-0.44	-0.59	-0.22	-2.49	0.64	-0.53	1.3	-1.3	-1.3
Interest coverage	—	75.4	113.3	71.8	—	—	—	—	—	-72.7	-72.7
Effective tax rate	0%	33.1%	25.1%	40.1%	49.5%	0%	0%	0%	0%	0%	0%

Per share

Metric	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	Current
Revenue per share	4.99	7.14	7.23	7.75	6.83	3.86	4.46	4.44	3.85	—	—
EPS (basic)	0.28	1.22	1.11	0.83	0.28	-0.7	-0.12	-0.19	-0.72	—	—
EPS (diluted)	0.28	1.22	1.1	0.83	0.28	-0.7	-0.12	-0.19	-0.72	—	—
Book value per share	2.16	2.86	3.39	3.4	3.05	2.26	2.19	1.9	1.16	—	—
FCF per share	0.51	1.31	1.44	1.22	0.48	-0.92	0.04	0.83	-0.29	—	-0.3
Cash per share	0.5	0.72	1.49	1.45	1.32	0.51	0.36	0.84	0.34	—	—
Capex per share	0.32	0.37	0.22	0.22	0.3	0.15	0.03	0.03	0.03	—	—

Capital allocation

Metric	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	Current
Capex / revenue	6.49%	5.16%	3.01%	2.79%	4.45%	3.98%	0.73%	0.74%	0.71%	0.26%	0.26%
Capex / operating cash flow	39.3%	23.7%	14.5%	15.3%	37.3%	-30.5%	10.2%	4.95%	-56.9%	4.44%	4.78%
Payout ratio	214.5%	48.9%	53.7%	82.8%	257.5%	-25.7%	-42%	-109.4%	-19.2%	0%	0%
Dividend yield	5.91%	2.42%	2.91%	4.34%	7.86%	3.52%	0.71%	4.26%	4.7%	—	—

Period	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24
Revenue	$6.5M	$6.5M	$6.5M	$5.7M	$5.9M	$5.5M	$5.7M	$5M	$5.4M	$4.7M	$5.2M	$4.4M
YoY change	+13.9%	+7%	-2.35%	-11.4%	-9.97%	-15%	-12.5%	-12.4%	-8.57%	-14.6%	-9.27%	-11.5%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Cash & short-term investments	2.7M	3.9M	8.2M	8M	7.3M	2.8M	2M	4.8M	2M	1.4M
Receivables	3.5M	5.8M	4.5M	4.8M	3.8M	3.4M	4.1M	3.7M	3.7M	2.5M
Inventory	—	—	—	—	—	—	—	—	—	—
Total current assets	8.1M	10.9M	13.9M	13.9M	12.9M	9.6M	10.3M	10M	6.8M	4.9M
Property, plant & equipment	13.1M	13.4M	11.8M	10.2M	10.9M	9.2M	6.7M	4.6M	3.1M	2.1M
Goodwill & intangibles	—	—	—	—	—	—	—	—	—	—
Total assets	22M	25M	26.5M	25M	27.5M	24M	21.6M	18.7M	12.3M	8.3M
Accounts payable	747K	1.4M	398K	682K	617K	577K	994K	448K	752K	462K
Short-term debt	1.6M	1.1M	957K	416K	1.6M	1.6M	1.6M	1.3M	1.4M	689K
Total current liabilities	3.6M	4.5M	4.2M	4.1M	5.8M	3.9M	5.8M	5.7M	4.7M	2.7M
Long-term debt	4.3M	2.2M	2.4M	1.2M	4.3M	7.3M	3.5M	2.2M	945K	477K
Total liabilities	10.4M	9.4M	7.9M	6.2M	10.7M	11.5M	9.3M	8M	5.7M	3.2M
Shareholders' equity	11.7M	15.6M	18.6M	18.7M	16.8M	12.5M	12.2M	10.8M	6.7M	5.1M
Total debt	5.9M	3.4M	3.4M	1.6M	6M	8.9M	5.1M	3.6M	2.3M	1.2M
Net debt	3.2M	-557K	-4.8M	-2.4M	-1.3M	6.1M	3.1M	-1.2M	334K	-251K

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24
Cash & short-term investments	2.1M	1.8M	3.5M	4.8M	4.4M	2.4M	1.4M	2M	1.4M	1.4M	1.4M	1.4M
Receivables	4.7M	4.4M	5M	3.7M	4.1M	4M	4.6M	3.7M	3.9M	3.1M	3.3M	2.5M
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	10.5M	10.9M	10.7M	10M	9.5M	8.2M	7.9M	6.8M	6.2M	6M	6M	4.9M
Property, plant & equipment	6.1M	5.6M	5.1M	4.6M	4.2M	3.8M	3.4M	3.1M	2.8M	2.5M	2.2M	2.1M
Goodwill & intangibles	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	21M	20.4M	20.5M	18.7M	17.9M	16.4M	14.1M	12.3M	11.2M	10.1M	9.7M	8.3M
Accounts payable	722K	598K	857K	448K	785K	806K	817K	752K	1.1M	662K	994K	462K
Short-term debt	1.6M	1.4M	1.3M	1.3M	1.4M	1.4M	1.4M	1.4M	1.3M	1.2M	983K	689K
Total current liabilities	5.3M	5.3M	6.2M	5.7M	5.8M	5.6M	5.4M	4.7M	4.2M	3.7M	3.8M	2.7M
Long-term debt	3.2M	2.9M	2.6M	2.2M	2M	1.6M	1.3M	945K	687K	623K	596K	477K
Total liabilities	8.5M	8.5M	8.8M	8M	7.7M	7.3M	6.7M	5.7M	4.9M	4.4M	4.4M	3.2M
Shareholders' equity	12.5M	11.9M	11.7M	10.8M	10.2M	9.1M	7.4M	6.7M	6.3M	5.7M	5.4M	5.1M
Total debt	4.7M	4.3M	3.9M	3.6M	3.3M	3M	2.6M	2.3M	2M	1.9M	1.6M	1.2M
Net debt	2.6M	2.6M	467K	-1.2M	-1.1M	541K	1.3M	334K	539K	434K	174K	-251K

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24
Net income	1.5M	6.7M	6.1M	4.6M	1.5M	-3.9M	-665K	-1.1M	-4.2M	-1.9M
Depreciation & amortization	1.7M	2.3M	2.8M	3.1M	2.9M	3.6M	3.7M	3.3M	2.7M	2.1M
Stock-based compensation	674K	671K	582K	594K	759K	563K	743K	872K	908K	917K
Change in working capital	441K	-1.3M	193K	-133K	-345K	-2.8M	-1.6M	1.2M	-391K	15K
Operating cash flow	4.5M	8.5M	8.3M	7.8M	4.5M	-2.8M	1.8M	3.8M	-276K	1.1M
Capital expenditure	-1.8M	-2M	-1.2M	-1.2M	-1.7M	-851K	-182K	-187K	-157K	-51K
Investing cash flow	-1.8M	-2M	-1.2M	-5.4M	2.1M	-858K	-220K	-208K	-159K	-51K
Dividends paid	-3.2M	-3.3M	-3.3M	-3.8M	-4M	-993K	-279K	-1.2M	-799K	0
Share repurchases	—	—	—	-93K	-33K	-9K	—	—	—	-2.6M
Financing cash flow	-3.6M	-5.8M	-3.3M	-5.6M	-3M	501K	-967K	-1.9M	-1.1M	-2.2M
Net change in cash	-889K	690K	3.8M	-3.2M	3.6M	-3.1M	606K	1.7M	-1.5M	-1.1M
Free cash flow	2.8M	7.2M	7.9M	6.7M	2.6M	-5.1M	232K	4.7M	-1.6M	842K

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24
Net income	39K	-338K	-97K	-688K	-384K	-726K	-2.1M	-945K	-688K	-827K	-535K	189K
Depreciation & amortization	860K	867K	827K	762K	714K	696K	685K	575K	551K	664K	453K	413K
Stock-based compensation	179K	238K	277K	178K	177K	143K	401K	187K	297K	287K	240K	93K
Change in working capital	-1.1M	-447K	1.6M	1.1M	-75K	-186K	-1.2M	937K	-75K	-118K	-70K	192K
Operating cash flow	22K	320K	1.4M	1.6M	273K	-507K	-948K	747K	85K	6K	88K	887K
Capital expenditure	-10K	1K	-51K	-127K	-20K	0	-88K	-133K	0	-24K	-6K	-21K
Investing cash flow	-3K	-24K	-58K	-123K	-52K	8K	-88K	-103K	13K	42K	10K	-21K
Dividends paid	—	—	-394K	-399K	—	—	0	0	—	—	0	0
Share repurchases	—	—	0	—	—	—	0	—	—	—	0	-2.6M
Financing cash flow	-174K	-175K	-568K	-540K	-72K	-74K	-74K	-74K	-75K	-76K	-294K	-3.1M
Net change in cash	-155K	121K	786K	892K	149K	-573K	-1.1M	570K	23K	-28K	-196K	-2.3M
Free cash flow	302K	288K	2.2M	1.9M	-266K	-1M	-1M	637K	-481K	81K	249K	993K

Psychemedics Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement